Table 1

 Reimbursement practices (% where it is standard, percentage of projects that reimburse, and typical amounts provided) by organisation type, main target group, and main research method

Reimbursement is standard* (n = 97)†Percentage of projects that reimburse (n = 64)‡Typical reimbursement amounts provided ($AUD)
n%MedianRangeMedianRange
*Standard refers to occurring in the majority of projects.
†Data missing for three respondents.
‡Where reimbursement is provided at all.
§Data missing for four respondents.
¶Data missing for three respondents.
**Data missing for one respondent.
ATSI, Aboriginal and Torres Strait Islander; AUD, Australian dollars.
Organisation type§
    Research centre/institute (n = 25)1144501–10022.505–100
    Hospital (n = 21)629501–10020.006–100
    Government (n = 9)44410060–10025.0020–75
    University (n = 37)1232735–10020.0015–110
    Market research (n = 3)331–6560.00
    Pharmaceutical company (n = 1)25200.00
Target group¶
    Drug dependent (n = 19)12637820–10020.0015–100
    Children/youth (n = 11)436451–7515.0010–20
    Health professionals (n = 6)1175030–100110.00
    ATSI (n = 5)240605–10015.005–25
    Patients (n = 20)420231–100100.006–200
    General population (n = 11)436751–10025.0020–60
    Mix (n = 25)624255–10025.0015–110
Method**
    Mixed (qualitative and quantitative) (n = 37)1130501–10020.006–75
    Epidemiology (n = 17)6357810–10020.0015–30
    Evaluation (n = 7)23372–100110.005–110
    Clinical research (n = 32)1134551–10040.0020–200
    Market research (n = 4)250631–9025.0025–60
    Social research (n = 2)150601–10020.0020–25